Ryan Specialty Holdings, Inc. (RYAN) Stock Price & How to Invest
Last updated July 2026
Short answer
Ryan Specialty (NYSE: RYAN) is a specialty insurance intermediary that runs wholesale brokerage and delegated-underwriting (MGU) businesses, so investing in it is a bet on continued growth in the excess and surplus (E&S) insurance market and on the firm's acquisition-driven expansion. The stock trades at a premium multiple, so the picture hinges on organic growth holding up as property rates soften.
RYAN stock price
As of 2026-07-24, Ryan Specialty Holdings, Inc. (RYAN) last closed at $41.75, down 37.0% over the past year. Over the past 52 weeks it has traded between $29.39 and $66.25.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Ryan Specialty Holdings, Inc.'s investor relations page. Walnut is informational, not investment advice.
What does Ryan Specialty Holdings, Inc. (RYAN) do?
Ryan Specialty Holdings is an international specialty insurance intermediary founded by Patrick Ryan (who also founded Aon). It sits between retail insurance brokers and carriers, operating two core engines: wholesale brokerage (led by RT Specialty, one of the largest E&S and binding-authority platforms in the US) and underwriting management, where its managing general underwriters (MGUs) hold delegated authority from carriers to underwrite niche risks in areas like energy, healthcare, construction, and enterprise risk. It does not take underwriting risk on its own balance sheet; it earns commissions and fees for placing and structuring hard-to-place specialty coverage.
The investment picture is one of a fast-growing, acquisitive distributor riding the multi-year shift of business into the excess and surplus lines market. Revenue reached roughly $795 million in Q1 2026 (up about 15% year over year, with organic growth near 12%), and the company has partnered with 55-plus firms through acquisition since inception. The tension is valuation and cyclicality: RYAN trades at a rich trailing multiple, and management has flagged that pronounced property-rate declines and intensifying competition are pressuring organic growth and margins into 2026.
What's driving Ryan Specialty Holdings, Inc. (RYAN)?
1. E&S market tailwind
Ryan Specialty is a leading intermediary in the excess and surplus lines market, which has grown for years as more complex, catastrophe-exposed, and hard-to-place risks flow out of the standard admitted market. As long as this structural migration continues, it feeds Ryan's wholesale placement and binding-authority volumes.
2. Delegated underwriting (MGU) mix
The Underwriting Management specialty, where MGUs hold delegated authority from carriers, generated a meaningful share of net commissions and fees and carries attractive economics. Expanding this higher-margin, stickier business is a core part of the growth story and helps diversify away from pure brokerage.
3. Acquisition-led expansion
Ryan has built scale through 55-plus acquisitions of specialty firms and MGUs across geographies, and continues to acquire teams and books to add niches and international reach. Deployed capital and integration of these deals contribute a few points of growth on top of organic gains.
4. Organic growth engine
The firm has posted double-digit organic growth for several years, driven by new business wins, share gains from retail brokers, and specialty expertise. Sustaining organic growth as insurance pricing normalizes is the swing factor for the multiple.
What are the risks to Ryan Specialty Holdings, Inc. (RYAN)?
The biggest near-term risk is insurance-pricing cyclicality: management has pointed to pronounced property-rate declines and intensifying competition, guiding to mid-single-digit organic growth and a modest margin decline for the year, with one quarter guided near zero organic growth. Softer rates directly reduce commission-based revenue. The stock also trades at a high trailing multiple, so any growth disappointment can compress the valuation sharply. Acquisition-heavy growth brings integration, goodwill, and leverage risk, and the company carries a meaningful debt load. Finally, it depends on relationships with carriers for delegated underwriting capacity, which can tighten in a downturn, and it operates in a competitive field against larger and well-capitalized wholesalers.
How is Ryan Specialty Holdings, Inc. (RYAN) valued? (approximate, July 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Ryan Specialty Holdings, Inc.'s investor relations page or your broker.
- Revenue (TTM): ~$3.0B
- Q1 2026 revenue: ~$795M (up ~15% YoY)
- Organic growth (Q1 2026): ~11.8%
- Adjusted EBITDA margin: ~29%
- Market cap: ~$11B
- P/E (TTM): ~54x (fwd ~19x)
Ryan Specialty grew Q1 2026 revenue about 15% to roughly $795 million and returned to a quarterly net profit, with adjusted EPS up about 20%. The trailing P/E near 54x looks steep and reflects growth expectations, while the forward multiple near 19x is far lower because analysts expect earnings to catch up. Management trimmed full-year organic growth guidance to mid-single digits and expects some margin decline as property rates soften.
Who competes with Ryan Specialty Holdings, Inc. (RYAN)?
Large wholesale brokers
Amwins and CRC Group are the other two members of the big-three wholesalers alongside Ryan's RT Specialty, competing directly on E&S placement, binding authority, and specialty breadth. Amwins is generally the largest by premium placed.
Public diversified brokers
Arthur J. Gallagher (via Risk Placement Services) and Brown & Brown (via Bridge Specialty) run sizable wholesale and program platforms, making them the closest public-company comparables and competitors for talent, teams, and acquisitions.
MGUs and program specialists
A fragmented field of managing general agents, MGUs, and program administrators competes for delegated underwriting authority and niche specialty books, the higher-margin business Ryan is trying to expand.
How to invest in Ryan Specialty Holdings, Inc. (RYAN)
There are three common ways to get RYAN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so RYAN sits alongside other stocks that express the same thesis.
Walnut takes the basket route. Describe a thesis where RYAN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on Ryan Specialty Holdings, Inc. (RYAN)
RYAN is a high-multiple, growth-oriented play on specialty and E&S insurance distribution, with property-rate softening and integration risk as the main things to weigh.
More on Ryan Specialty Holdings, Inc. (RYAN)
Whether RYAN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is RYAN a buy?, and where the stock could go from here in the RYAN stock forecast.
For income investors, whether RYAN pays a dividend and how the payout looks is covered in does RYAN pay a dividend?
Build a basket around RYAN with Walnut
Use Ryan Specialty Holdings, Inc. as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What does Ryan Specialty do?
+
It is a specialty insurance intermediary that connects retail insurance brokers with carriers. It runs wholesale brokerage (placing hard-to-place risks, largely in the E&S market) and underwriting management, where its MGUs hold delegated authority to underwrite niche risks for carriers. It earns commissions and fees, not underwriting profit.
Does Ryan Specialty take on insurance risk?
+
No. Ryan is an intermediary and distributor, not a risk-bearing insurer. It places coverage and underwrites on behalf of carriers under delegated authority, earning commissions and fees. The underwriting risk sits with the carriers that provide the capacity.
What is the excess and surplus (E&S) market and why does it matter to RYAN?
+
E&S covers risks that the standard admitted insurance market will not write, such as complex, catastrophe-exposed, or emerging exposures. Ryan is a leading wholesale intermediary in E&S, so the multi-year growth of that market has been a key tailwind for its placement volumes.
How did Ryan Specialty perform in Q1 2026?
+
Revenue was roughly $795 million, up about 15% year over year, with organic growth near 12%. The company returned to a quarterly net profit, and adjusted EPS rose about 20%. Adjusted EBITDA margin was around 29%.
Why is RYAN's P/E so high?
+
The trailing P/E near 54x reflects strong growth expectations and the fact that reported earnings have been held down by acquisition-related and non-cash items. The forward P/E is far lower, near 19x, because analysts expect earnings to rise as the business scales.
What are the main risks for Ryan Specialty?
+
Softening property-insurance rates and rising competition are pressuring organic growth and margins, and much of the revenue is commission-based and cyclical. The stock's premium valuation adds downside if growth disappoints, and acquisition-heavy expansion brings integration and leverage risk.
Who competes with Ryan Specialty?
+
Its closest wholesale rivals are Amwins and CRC Group, the other members of the big-three wholesalers. Public comparables include Arthur J. Gallagher (Risk Placement Services) and Brown & Brown (Bridge Specialty), plus a fragmented field of MGAs and program specialists.
Does Ryan Specialty pay a dividend?
+
Ryan Specialty has historically prioritized reinvestment and acquisitions over a large dividend, so income has not been the main reason investors hold it. Check the latest investor materials for current dividend and capital-return policy, since these can change.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Ryan Specialty Holdings, Inc.'s investor relations page or your broker before making investment decisions.